Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$3.77 - $8.39 $2,574 - $5,730
683 New
683 $5,000
Q4 2022

Feb 13, 2023

BUY
$6.88 - $9.55 $3,708 - $5,147
539 New
539 $4,000
Q3 2021

Nov 05, 2021

SELL
$21.65 - $39.49 $2,684 - $4,896
-124 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$15.5 - $22.48 $1,922 - $2,787
124 New
124 $3,000
Q4 2020

Feb 09, 2021

SELL
$9.4 - $16.7 $2,820 - $5,010
-300 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$10.54 - $24.96 $3,161 - $7,488
300 New
300 $3,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $336M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.